Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose prasugrel vs clopidogrel in elderly ACS patients undergoing early PCI
2012-002882-37Phase 4Terminated
- Sponsor
- Santa Maria Nuova
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute coronary syndrome (ACS) comparing Reduced-dose prasugrel with Standard-dose clopidogrel (2 arms). Primary endpoint: Primary composite endpoint. Started Sep 2012; status: terminated.
02
Drugs
prasugrelclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2012-002882-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002882-37.